MIRA INFORM REPORT

Report Date :

31.10.2013

IDENTIFICATION DETAILS

Name :	NATCO PHARMA, INC.
Registered Office :	297 Mine Bank Road, Wellsville, PA 17365
Country :	United States
Financials (as on) :	2012
Date of Incorporation :	10.10.2006
Legal Form :	Corporation – Profit
Line of Business :	Subject primarily operates in the Pharmacies and Drug Stores industry.
No. of Employees :	70

RATING & COMMENTS

MIRA’s Rating :

Ba

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory
Payment Behaviour :	No complaints
Litigation :	--

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2013

Country Name	Previous Rating (31.12.2012)	Current Rating (31.03.2013)
United States	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

UNITED STATES - ECONOMIC OVERVIEW

The US has the largest and most technologically powerful economy in the world, with a per capita GDP of $49,800. In this market-oriented economy, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, they face higher barriers to enter their rivals' home markets than foreign firms face entering US markets. US firms are at or near the forefront in technological advances, especially in computers and in medical, aerospace, and military equipment; their advantage has narrowed since the end of World War II. The onrush of technology largely explains the gradual development of a "two-tier labor market" in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the United States into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression. To help stabilize financial markets, in October 2008 the US Congress established a $700 billion Troubled Asset Relief Program (TARP). The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009 the US Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012 the federal government reduced the growth of spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2011, the direct costs of the wars totaled nearly $900 billion, according to US government figures. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries. In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that will extend coverage to an additional 32 million American citizens by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on health care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight. In December 2012, the Federal Reserve Board announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short term rates near zero until unemployment drops to 6.5% from the December rate of 7.8%, or until inflation rises above 2.5%. Long-term problems include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits - including significant budget shortages for state governments

Source : CIA

Company name and address

NATCO PHARMA, INC.

Address: 297 Mine Bank Road, Wellsville, PA 17365 - USA

Telephone: +1 717-432-7779

Fax: +1 717-569-4406

Website: -

Corporate ID#: 4232479

State: Delaware

Judicial form: Corporation – Profit

Date incorporated: 10-10-2006

Stock: -

Value: -

Name of manager: Sivaprasad RAVIPATI

ACTIVITIES & OPERATIONS

IST

Business:

The Company is a subsidiary of NATCO PHARMA LTD. an Indian pharmaceutical company established in 1981.

The Company has a professional set up with expertise in Quality systems, Regulatory requirements, Warehousing and logistics, Marketing, Distribution and Sales to serve the U.S. market.

Company is primarily operates in the Pharmacies and Drug Stores industry

EIN: 23-2598914

Staff: 70

Operations & branches:

At the headquarters, we find the corporate office.

SHAREHOLDERS & MANAGERS

Shareholders:

NATCO PHARMA LTD.

Road No.2, Banjara Hills
Hyderabad-500 033 - India

Management:

Sivaprasad RAVIPATI is the President

As far as we know, he is not involved in other local corporations.

Subsidiaries

And partnership: None

FINANCIALS

In United States, privately held corporations are not required to publish any financials.

On a direct call, nobody accepted to answer our questions.

We sent a fax but no answer received.

However, sales estimate for year 2012 is in the range of USD 10,000,000=

The business is said to be profitable.

Banks: Citibank

…

LEGAL FILINGS

Legal filings & complaints:

State: New Jersey

Case number: 2:11-cv-01455-SDW-MCA

Plaintiff: GILEAD SCIENCES, INC. et al

Defendant: NATCO PHARMA INC. et al
Susan D. Wigenton, presiding
Madeline C. Arleo, referral
Date filed: 03/15/2011
Date of last filing: 05/23/2013

Cause: Patent: Infringement

State: New Jersey

Case number: 2:10-cv-05197-SDW-MCA

Plaintiff: CELGENE CORPORATION

Defendant: NATCO PHARMA INC.
Susan D. Wigenton, presiding
Madeline C. Arleo, referral
Date filed: 10/08/2010
Date of last filing: 10/22/2013

Cause: Patent infringement

Secured debts summary (UCC):

File number: 2007082903123

Date filed: 08-29-2007

Lapse date: 08-29-2017

Secured Party: Associated Wholesalers, Inc.

US Route 422, Robesonia, PA 19551

Haut du formulaire

COMPANY CREDIT HISTORY

Trade references:

Date reported: October 2013

High credit: USD 15,000

Now owing: 0

Past due: 0

Last purchase: September 2013

Line of business: Office supply

Paying status: On terms

Date reported: October 2013

High credit: USD 80,000

Now owing: 0

Past due: 0

Last purchase: September 2013

Line of business: Payroll

Paying status: As agreed

Date reported: October 2013

High credit: USD 300

Now owing: 0

Past due: 0

Last purchase: September 2013

Line of business: Telecommunications

Paying status: On terms

Domestic credit history:

National Credit Bureaus gave a correct credit rating.

Other comments:

The Company maintains its business.

The Company is in good standing.

This means that all local and federal taxes were paid on due date.

The risk is low.

Our opinion:

A business connection may be conducted.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.61.49
UK Pound	1	Rs.98.71
Euro	1	Rs.84.49

INFORMATION DETAILS

Report Prepared by :

NIS

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.